Clínica e Investigación en Arteriosclerosis (English Edition), Journal Year: 2023, Volume and Issue: 35(4), P. 206 - 217
Published: July 1, 2023
Language: Английский
Clínica e Investigación en Arteriosclerosis (English Edition), Journal Year: 2023, Volume and Issue: 35(4), P. 206 - 217
Published: July 1, 2023
Language: Английский
Kidney Medicine, Journal Year: 2025, Volume and Issue: unknown, P. 100996 - 100996
Published: March 1, 2025
Language: Английский
Citations
0Atención Primaria, Journal Year: 2025, Volume and Issue: 57(10), P. 103260 - 103260
Published: March 26, 2025
Language: Английский
Citations
0American Heart Journal, Journal Year: 2025, Volume and Issue: unknown
Published: March 1, 2025
Therapeutic anticoagulation (AC) is standard care for pulmonary embolism (PE). Endovascular therapy with mechanical thrombectomy (MT) commonly performed PE and well-studied in single-arm trials. The efficacy benefit of MT over AC alone a randomized fashion remains unstudied. STORM-PE (ClinicalTrials.gov Identifier: NCT05684796) post-market, international, open-label trial conducted partnership Pulmonary Embolism Response Team ConsortiumTM. Up to 100 patients confirmed acute intermediate-high-risk demonstrated by right ventricular (RV) dysfunction right-to-left (RV/LV) ratio ≥1.0 elevated cardiac biomarkers will be 1:1 receive or plus Computer Assisted Vacuum Thrombectomy (CAVT) the Indigo Aspiration System (Penumbra Inc.). primary outcome mean change RV/LV at 48 hours, assessed computed tomographic angiography (CTPA) adjudicated blinded, independent imaging Core Lab. Additional endpoints are composite major adverse events, functional outcomes (6-minute walk test, New York Heart Association classification, post-venous thromboembolism status scale, modified Medical Research Council Dyspnea Scale, Borg Scale), quality life (Pulmonary Quality Life Questionnaire EQ-5D-5L), mortality, symptomatic recurrence through 90 days. A Clinical Events Committee adjudicate events causality attribution an Data Safety Monitoring Board oversee study. funded Penumbra Inc. help inform future guidelines standards related frontline treatment using CAVT PE. STORM-PE, NCT05684796, registered https://clinicaltrials.gov/study/NCT05684796.
Language: Английский
Citations
0Metabolism, Journal Year: 2025, Volume and Issue: unknown, P. 156297 - 156297
Published: May 1, 2025
Language: Английский
Citations
0Current Problems in Cardiology, Journal Year: 2024, Volume and Issue: 49(3), P. 102348 - 102348
Published: Jan. 21, 2024
Despite guideline recommendations, strategies for implementing cardiac rehabilitation (CR) in patients with acute aortic dissection (AAD) are not well established little evidence to risk stratify prudent and effective guidelines the many required variables. We conducted a systematic review of studies (2004-2023) reporting CR following type A (TA) B (TB) AAD. Our is limited open surgical repair TA medical treatment TB. total 5 were included (4 TA-AAD 1 TB-AAD) qualitative analysis. In general, observational data 311 who had an overall favorable effect AAD consisting modestly improved exercise capacity work load during cycle cardiopulmonary test (TB-AAD), quality life (QoL). No adverse events reported symptom pre-CR treadmill or VO2 max CR. Given potential this high population without adequate important variables such as safe time from post-op CR, intensity training, duration frequency sessions followup it moderate sized designed trial patients' surgery medically treated TB-AAD standardized based therapy physical discharge randomized versus usual care. PROSPERO registry ID: CRD42023392896.
Language: Английский
Citations
2Hellenic Journal of Cardiology, Journal Year: 2024, Volume and Issue: unknown
Published: May 1, 2024
The aim of this study was to present the burden cardiovascular disease (CVD) and its related risk factors based on a 20-year observation period (2002-2022).
Language: Английский
Citations
2Clínica e Investigación en Arteriosclerosis, Journal Year: 2023, Volume and Issue: 35(4), P. 206 - 217
Published: March 6, 2023
Language: Английский
Citations
5Clínica e Investigación en Arteriosclerosis, Journal Year: 2023, Volume and Issue: 35(2), P. 91 - 100
Published: March 1, 2023
Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control lipid metabolism disorders is a key challenge cardiovascular prevention that far from being achieved real clinical practice. There great heterogeneity reports Spanish laboratories, which may contribute its poor control. For this reason, working group scientific societies involved care patients at vascular risk, has prepared document with consensus proposal on determination basic profile prevention, recommendations for realization and unification criteria incorporate goals appropriate risk laboratory reports.
Language: Английский
Citations
4Patient Education and Counseling, Journal Year: 2023, Volume and Issue: 119, P. 108082 - 108082
Published: Nov. 18, 2023
Language: Английский
Citations
4Clínica e Investigación en Arteriosclerosis (English Edition), Journal Year: 2024, Volume and Issue: 36(1), P. 1 - 11
Published: Jan. 1, 2024
Citations
1